OasisLMS

As part of IASLC’s Lung Cancer Considered world language series, Dr. Mihaela Aldea moderates a discussion in Romanian with Dr. Miruna Grecea and Dr. Andrei Ungureanu about the diagnosis, molecular testing, and treatment strategies for a patient with locally advanced, unresectable EGFR-mutant non-small cell lung cancer in Romania. The episode explores multidisciplinary approaches, the use of osimertinib as consolidation therapy post-chemoradiotherapy based on the LAURA trial, and considerations for follow-up and disease progression.

Podcast Guest Host:

• Mihaela Aldea, MD, PhD, Thoracic Oncology and Precision Medicine Group, Department of Medical Oncology, Gustave Roussy, Villejuif, France

Podcast Guests: 

• Miruna Grecea, MD, Medical Oncologist, Department of Medical Oncology, Ion Chiricuta Cancer Institute, Cluj-Napoca, Romania
• Andrei Ungureanu, MD, Medical Oncologist, Amethyst Oncology Clinica, Cluj-Napoca, Romania